# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001185185-26-000846
Filing Date
2026-03-12
Accepted
2026-03-11 18:19:08
Documents
38
Period of Report
2026-03-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | igc8k031126.htm iXBRL | 8-K | 31938
2 | EXHIBIT 10.1 | igcex10-1.htm | EX-10.1 | 57963
3 | EXHIBIT 10.2 | igcex10-2.htm | EX-10.2 | 90682
4 | EXHIBIT 10.3 | igcex10-3.htm | EX-10.3 | 20144
5 | GRAPHIC | image_001.jpg | GRAPHIC | 5199
6 | GRAPHIC | ex10-3_001.jpg | GRAPHIC | 244430
7 | GRAPHIC | ex10-3_002.jpg | GRAPHIC | 226858
8 | GRAPHIC | ex10-3_003.jpg | GRAPHIC | 88475
9 | GRAPHIC | ex10-3_004.jpg | GRAPHIC | 244196
10 | GRAPHIC | ex10-3_005.jpg | GRAPHIC | 85164
11 | GRAPHIC | ex10-3_006.jpg | GRAPHIC | 445130
12 | GRAPHIC | ex10-3_007.jpg | GRAPHIC | 483554
13 | GRAPHIC | ex10-3_008.jpg | GRAPHIC | 460175
14 | GRAPHIC | ex10-3_009.jpg | GRAPHIC | 502757
15 | GRAPHIC | ex10-3_010.jpg | GRAPHIC | 423499
16 | GRAPHIC | ex10-3_011.jpg | GRAPHIC | 465422
17 | GRAPHIC | ex10-3_012.jpg | GRAPHIC | 456328
18 | GRAPHIC | ex10-3_013.jpg | GRAPHIC | 451856
19 | GRAPHIC | ex10-3_014.jpg | GRAPHIC | 448503
20 | GRAPHIC | ex10-3_015.jpg | GRAPHIC | 457727
21 | GRAPHIC | ex10-3_016.jpg | GRAPHIC | 469046
22 | GRAPHIC | ex10-3_017.jpg | GRAPHIC | 450272
23 | GRAPHIC | ex10-3_018.jpg | GRAPHIC | 261755
24 | GRAPHIC | ex10-3_019.jpg | GRAPHIC | 445819
25 | GRAPHIC | ex10-3_020.jpg | GRAPHIC | 102302
26 | GRAPHIC | ex10-3_021.jpg | GRAPHIC | 61848
27 | GRAPHIC | ex10-3_022.jpg | GRAPHIC | 137230
| Complete submission text file | 0001185185-26-000846.txt |  | 10631898

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
28 | XBRL SCHEMA FILE | igc-20260306.xsd | EX-101.SCH | 3010
29 | XBRL LABEL FILE | igc-20260306_lab.xml | EX-101.LAB | 34235
30 | XBRL PRESENTATION FILE | igc-20260306_pre.xml | EX-101.PRE | 22355
40 | EXTRACTED XBRL INSTANCE DOCUMENT | igc8k031126_htm.xml | XML | 3070

Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-529-4996
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32830 | Film No.: 26744835
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)